Resonance Health Ltd has released a press release.
R&D Tax Incentive
Filed with ASX ·
On 6ix: 6ix.com/news/randd-tax-incentive
6ix hasn’t read this filing yet.
Story so far
Earlier from Resonance Health
- Change of Director's Interest Notice
- New Work Order to provide services for Clinical Trial
- Pause in Trading
- Change of Substantial Shareholder Notification
- Additional Information on Announcement Dated 23 August 2018
Later from Resonance Health
- FDA Clearance Granted for FerriSmart
- Response to ASX Price and Volume Query
- Execution of License Agreement
- Execution of Distribution Agreement with EnvoyAI
- R&D Activities Update and Appendix 3B
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health